Vitex (Chasteberry)
Best-in-class: Vitex (Chasteberry)
The premier women's hormone-balancing herb, working on the pituitary to support progesterone and ease PMS and cycle irregularity.
Vitex (Chasteberry) quick facts
| Suggested dose | As directed, taken in the morning; give it 2–3 cycles. |
| How often | Daily, and judged over 2-3 full cycles |
| Who it's for | PMS, PMDD, cycle regularity and fertility support (women). |
The best-evidenced botanical for PMS and luteal-phase defect, with multiple positive RCTs. It takes about three cycles to work, which is the most common reason people abandon it early. Because the mechanism is dopaminergic it interacts with dopamine agonists and antagonists, including antipsychotics. Not appropriate alongside hormonal contraception or in pregnancy.
How Vitex (Chasteberry) actually works
Vitex binds dopamine D2 receptors on pituitary lactotrophs, which suppresses prolactin release. Lower prolactin permits normal luteal progesterone production — so this is a dopaminergic drug acting on the pituitary, and the herbal parallel to cabergoline rather than a general hormone balancer.
Where to get Vitex (Chasteberry)
Find Vitex (Chasteberry) on iHerb →The evidence for Vitex (Chasteberry)
Graded by what exists behind each claim.
✅ Clinically validated
- Meta-analyses support reduced PMS and PMDD symptoms and improved cycle regularity.
- Lowers prolactin and supports the luteal phase.
📊 Correlative data
- Luteal-phase/progesterone issues track with the PMS patterns vitex helps.
🧪 Theoretical / extrapolated benefits
- Predicted to act as a dopamine D2 agonist at the pituitary, suppressing prolactin and thereby relieving the luteal-phase symptoms associated with mildly raised prolactin. That is an unusually specific mechanism for a botanical.
- The same mechanism predicts the problem: it can interfere with dopamine agonists and antipsychotics, it may affect fertility treatment, and it confounds a prolactin measurement — which is the one test most likely to give a treatable answer for absent periods.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What Vitex (Chasteberry) actually does
This is one of the few botanicals whose mechanism is a named receptor rather than a gesture at one, and the binding work has now been done on the exact extract the trials used. Lactotroph cells in the anterior pituitary secrete prolactin continuously and are held in check by dopamine arriving from the hypothalamus through the portal circulation, acting at the D2 receptor. Anything that agonizes D2 on a lactotroph lowers prolactin; anything that blocks it raises prolactin. That is why antipsychotics cause galactorrhea and why cabergoline treats a prolactinoma.
The constituents that do it in Vitex have been identified by class. Work on the Ze 440 extract examined diterpene and triterpene interactions with the dopamine D2 receptor directly Reinhardt 2024. Diterpenes are not the constituents most people assume are responsible — the flavonoids and the iridoid glycosides get most of the label space — and identifying the class that binds is what turns a folk remedy into a pharmacology.
The downstream consequence is a luteal-phase argument, not a progesterone-supplement argument. Mildly raised prolactin suppresses pulsatile gonadotropin-releasing hormone, which blunts the luteinizing hormone surge, which produces a corpus luteum that secretes less progesterone for less time. Lower the prolactin and the chain runs normally again. Vitex therefore does not contain progesterone and does not act on a progesterone receptor; it removes an upstream brake. The clinical work on hyperprolactinemia is where that mechanism is tested most directly Puglia 2023.
The mechanism also predicts its own side effects, which is the mark of a real one. Cycle changes in the first two or three months are what a shifted luteal phase looks like from the outside. Interference with dopamine agonists and antagonists follows from occupying the same receptor. And a prolactin measurement taken while somebody is on Vitex is a measurement of the drug as much as of the patient, which matters because prolactin is the one test most likely to give a treatable answer for absent periods.
Opioid receptor activity is the second, quieter part of the pharmacology. Vitex extracts also show activity at mu and kappa opioid receptors in binding work, which is a plausible route to the breast-tenderness and mood components of premenstrual symptoms independent of prolactin, and it is the part of the mechanism that has not been followed up in people.
Cell, rodent, human — and where it stops
Receptor to extract to trial is unusually intact here. The break is that the trials belong to specific preparations, and the shelf mostly does not sell them.
At the receptor. Ze 440's diterpenes and triterpenes were characterized against D2 Reinhardt 2024. Note what that sentence contains: not “chasteberry”, but a named, manufactured extract.
In people, pooled. A meta-analysis of double-blind randomized controlled trials of Vitex agnus-castus in premenstrual syndrome exists Csupor 2019, and a broader systematic review covers premenstrual, postmenstrual and infertility indications Rafieian-Kopaei 2017. The prolactin-lowering effect has its own clinical literature Puglia 2023.
And in a regulatory setting, which is the step almost no botanical reaches. Vitex agnus-castus fructus extract has been reviewed as an over-the-counter medicinal product in Japan alongside another European ethnopharmaceutical Hoshino 2018. A regulator assessing a defined extract for self-medication is a different evidentiary standard from a supplement facts panel, and it is a reason to take this plant more seriously than most of its neighbors on the shelf.
The obstacle is extract identity, and the meta-analysis inherits it. Pooling trials of different Vitex preparations assumes they are the same drug. They are not: the constituents that bind D2 are diterpenes Reinhardt 2024, and diterpene yield depends on solvent and on standardization target. A meta-analysis that mixes a carbon dioxide extract with an ethanolic tincture and a dried fruit powder is averaging three pharmacologies.
The second obstacle is that the population is defined by symptoms, not by a number. The trials recruit women with premenstrual symptoms rather than women with measured hyperprolactinemia. The mechanism predicts the biggest effect in the subgroup with mildly elevated prolactin, and almost no trial stratifies on it.
Vitex (Chasteberry) — which form, and does it matter
The evidence belongs to named extracts, and the name is the product. The D2 binding work was done on Ze 440 Reinhardt 2024 — a specific standardized extract with a specified solvent, drug-to-extract ratio and standardization marker. A capsule of milled chasteberry is not that. This is the same situation as a specific ginkgo or St John's wort extract carrying the trial data for a whole category, and it is stated much less often for Vitex.
Standardization markers on this plant point at the wrong molecules. Products are commonly standardized to agnuside, an iridoid glycoside, or to casticin, a flavonoid. Both are convenient analytical handles. Neither is the diterpene class that the receptor work implicates Reinhardt 2024. A product can hit its agnuside specification exactly and carry a different amount of the constituent that does the pharmacology.
Solvent decides the diterpene yield. Diterpenes are lipophilic; iridoid glycosides are not. A dried aqueous extract and a carbon dioxide or ethanolic extract of the same fruit are different products, and only one of them concentrates the fraction with the receptor activity. Where a product does not state its extraction solvent, the reader cannot tell which they have bought.
Dose figures do not transfer between forms, and this is where readers get hurt. A 20 mg dose of a concentrated standardized extract and a 400 mg dose of dried fruit powder can be reasonable or absurd depending entirely on the drug-to-extract ratio. Comparing milligrams across two products with different ratios compares nothing. The regulatory review of a defined extract as an OTC product exists precisely because the dose of a defined material can be specified Hoshino 2018.
And the practical form question: morning dosing is in the protocol for a reason. Prolactin has a strong sleep-entrained rhythm, peaking in the night. A once-daily dopaminergic agent taken in the morning is positioned to blunt that peak on the following cycle. It is a schedule that follows from the mechanism rather than from convenience.
What would have to be true, and how you would know it was not
1. Predict prolactin falls, and predict it is measured first. Baseline prolactin, drawn in the morning at least an hour after waking and away from breast stimulation, before starting. Prediction: a measurable fall by eight to twelve weeks in somebody whose baseline was mildly elevated Puglia 2023, and no change in somebody whose baseline was normal. This is the single most informative test on the page.
2. Predict a longer luteal phase before predicting fewer symptoms. The mechanism is upstream. Cycle tracking with a mid-luteal progesterone drawn about seven days before the expected period, over three cycles, is the read-out. Prediction: luteal-phase length increases before symptom scores change, because the symptom is downstream of the endocrine event.
3. Predict the meta-analytic effect and expect it to be modest. The pooled result across double-blind randomized trials is the honest expectation Csupor 2019, not the best single trial. Three cycles is the window; anything judged after one cycle is judged on noise.
4. The prediction that would falsify the mechanism. If a trial stratified by baseline prolactin and found identical symptom improvement in the normal-prolactin and high-prolactin groups, the D2 story would not be the explanation, and the opioid-receptor activity or a placebo response would have to carry it instead. That trial has not been done, and it is the one that would settle this.
5. Predict this confounds a diagnostic work-up, and plan around it. Anybody investigating absent or irregular periods should have prolactin, TSH, LH, FSH and estradiol measured before starting Vitex, not after. A dopaminergic agent lowers the very number a clinician would use to find a prolactinoma, and a normalized prolactin on treatment is not the same as a normal one.
What nobody has tested yet
Nobody has run the trial stratified on baseline prolactin. The mechanism predicts a responder subgroup Reinhardt 2024 Puglia 2023 and the trials recruit on symptoms Csupor 2019. One adequately powered trial that measured prolactin at entry and analyzed by tertile would explain most of the heterogeneity in this literature.
Nobody has compared extracts head to head. Ze 440 is characterized Reinhardt 2024 and the shelf sells a dozen unnamed alternatives. A randomized comparison of a defined extract against a milled fruit powder at label doses, with prolactin as the endpoint, has not been published and would take one small study.
Nobody has followed the opioid-receptor thread into a person. Binding activity at mu and kappa receptors is reported in the preclinical literature and has never been connected to a human outcome, which leaves an entire second mechanism unexamined.
And the fertility question remains open in both directions. The systematic review covers infertility indications alongside premenstrual ones Rafieian-Kopaei 2017, and the underlying trials are small. Whether Vitex helps, hinders or interacts with assisted reproduction protocols — where controlled ovarian stimulation depends on exactly the axis this plant touches — has not been studied at all.
Vitex (Chasteberry) — its own safety story, not its category's
The interaction list for this plant is short, specific and mechanistically forced, which makes it more serious than a long vague one. It occupies the dopamine D2 receptor Reinhardt 2024. That places it in direct opposition to D2 antagonists — most antipsychotics, metoclopramide, domperidone — and in additive combination with D2 agonists such as cabergoline, bromocriptine, pramipexole and ropinirole. Neither of those shows up as an altered drug concentration.
The effect on a diagnostic test is a safety issue in its own right. Prolactin is the test that finds a prolactinoma. A botanical that lowers prolactin can normalize the number that would otherwise have prompted imaging Puglia 2023, and the person taking it has no way to know that is what happened. Baseline before starting is not a nicety here.
Hormonal contraception and hormone therapy are a genuine unknown rather than a known danger. The mechanism is upstream of the ovary, and combined hormonal contraception already suppresses that axis, so what Vitex does on top of it has not been characterized. The regulatory review of the defined extract as an OTC product is the closest thing to an authoritative position on who should use it Hoshino 2018.
Early cycle changes are expected and are the mechanism, not a warning sign. Spotting, a shifted period and breast tenderness in the first two to three cycles are what a changing luteal phase looks like. Persisting beyond three cycles, or heavy bleeding at any point, is a reason to stop and be assessed rather than to persevere.
Stop on a positive pregnancy test. Prolactin rises physiologically in pregnancy and in lactation for reasons the body needs; a dopaminergic agent works against that, and there is no safety data to weigh against it. The trials that generated this page's evidence recruited non-pregnant women Csupor 2019 Rafieian-Kopaei 2017.
Sources read for this page
- Reinhardt JK. Vitex agnus castus Extract Ze 440: Diterpene and Triterpene's Interactions with Dopamine D2 Receptor. Int J Mol Sci 2024 · PMID 39519010
- Csupor D. Vitex agnus-castus in premenstrual syndrome: A meta-analysis of double-blind randomised controlled trials. Complement Ther Med 2019 · PMID 31780016
- Puglia LT. Vitex agnus castus effects on hyperprolactinaemia. Front Endocrinol (Lausanne) 2023 · PMID 38075075
- Rafieian-Kopaei M. Systematic Review of Premenstrual, Postmenstrual and Infertility Disorders of Vitex Agnus Castus. Electron Physician 2017 · PMID 28243425
- Hoshino T. European Ethnopharmaceuticals for Self-Medication in Japan: Review Experience of Vitis vinifera L., Folium Extract and Vitex agnus-castus L., Fructus Extract as OTC Drugs. Medicines (Basel) 2018 · PMID 29316611
How you would know if it worked
These are the markers that recommend this product on their own pages, so they are the ones that should move if it is doing what it is sold for.
- Progesterone — Vitex (chasteberry) has modest evidence for luteal support Retest: Mid-luteal phase across 1–2 cycles.
- Prolactin — Vitex is used in women but should be discussed with a provider Retest: Repeat any elevated value before acting; then per provider.
Draw before you start, not after. A result with nothing to compare it to answers nothing.
Vitex (Chasteberry) — safety & side effects
- Nausea, headache and acne early on are common and usually settle. Changes to your cycle in the first two to three months are expected — spotting or a shifted period is the mechanism working, not a warning.
- Do not combine with hormonal contraception, HRT, or dopamine agonists and antagonists (including some antipsychotics and Parkinson's medication) — it acts on dopamine receptors to lower prolactin and the interaction is real.
- Stop on a positive pregnancy test. Avoid with hormone-sensitive cancers.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Best-in-class brand pick
- Coach Cam's stacks and notes
- Fasted or with food, and when in the day
- Morning or night, and why that window
- Around training, or deliberately away from it
- What it must not share a window with
Everything above is free and stays free. Skool is where it becomes a plan — Vitex (Chasteberry) in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside Vitex (Chasteberry)
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| Prolactin | Dopaminergic — it lowers prolactin. That's the mechanism and this tracks it |
| TSH (Thyroid-Stimulating Hormone) | Hypothyroidism raises prolactin. Rule it out before treating the prolactin |
| Estradiol, Sensitive (LC/MS-MS) | Taken for cycle symptoms; know the baseline |
The Basics — Start Here panel covers these in one order — 4 markers, $32.40 with the discount applied.
Check results you already have → · All 103 markers A–Z
Vitex (Chasteberry) — frequently asked questions
What is Vitex (Chasteberry)?
The premier women's hormone-balancing herb, working on the pituitary to support progesterone and ease PMS and cycle irregularity.
What is the suggested dose of Vitex (Chasteberry)?
As directed, taken in the morning; give it 2–3 cycles. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find Vitex (Chasteberry) dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy Vitex (Chasteberry)?
Coach Cam sources Vitex (Chasteberry) from vetted, top-rated brands on iHerb — use the buy link on this page.
Vitex (Chasteberry) inside a finished plan
One arm of 1 Protocol Blueprint, free to read in full.
What Vitex (Chasteberry) is used for
Vitex (Chasteberry) appears under 3 goals in the goal router.
Related Hormonal & Wellness supplements
Where this goes next
Vitex (Chasteberry) is the luteal-phase arm of this plan. The page above is the free breakdown of one compound; the plan it belongs to — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.